Axcella Health Inc.
AXLADelisted Feb 15, 2024- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001633070
Axcella Health Inc. was delisted on Feb 15, 2024; its insiders filed their last Form 4 on Mar 3, 2023; 15 institutions reported holding it in 13F filings for Q3 2023, worth $17.1M in total; no superinvestor held it.
Q2 2023 vs. Q1 2023
How the institutions holding Axcella Health Inc. changed between Q1 2023 and Q2 2023.
All holders in Q2 2023All holders in Q1 2023
| Measure | Q1 2023 | Q2 2023 | Change |
|---|---|---|---|
| Holders | 29 | 30 | +1 |
| Shares | 49.1M | 47.9M | −1.12M (−2.3%) |
| Value | $23.6M | $10.5M | −$13.1M (−55.6%) |
New holders (4)
Institutions that held Axcella Health Inc. at the end of Q2 2023 but not at the end of Q1 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Morgan Stanley | 25,108 | $5.48K | 0.00% |
| Portside Wealth Group, LLC | 11,950 | $2.61K | 0.00% |
| Advisor Group Holdings, Inc. | 10 | $2 | 0.00% |
| Royal Bank of Canada | 572 | $0 | 0.00% |
Sold out (3)
Institutions that held Axcella Health Inc. at the end of Q1 2023 and filed for Q2 2023 without it.
| Institution | Shares, Q1 2023 | Value, Q1 2023 |
|---|---|---|
| Zacks Investment Management | 104,124 | $50.0K |
| Belpointe Asset Management LLC | 1,143 | $549 |
| Global Retirement Partners, LLC | 180 | $67 |